¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"CE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 6
CEP chronic eosinophilic pneumonia; chronic erythropoietic porphyria; congenital erythropoietic porphyria; continuing education program; cortical evoked potential; counter-electrophoresis
CEPA chloroethane phosphoric acid
CEPH cephalic; cephalosporin; Council on Education for Public Health
ceph cephalin
CEPH FLOC cephalin flocculation
CEQ Council on Environmental Quality
CER Conditioned Emotional Response; Á¶°ÇÈ­ °¨Á¤ ¹ÝÀÀ
CER capital expenditure review; ceramide; conditioned emotional response; control electrical rhythm; cortical evoked response
CERAD Consortium to Establish a Registry for Alzheimer disease
CERCLA The Comprehensive Environmental Response, Compensation, and Liability Act
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 6
CEA central amygdala
CEA central amygdaloid nucleus
CEAs Cost-effectiveness analyses
CEAs carotid endarterectomies
CEase Cholesterol esterase
CEB Calcium entry blocker
CEC Capillary electrochromatography
CEC Cerebral endothelial cell
CEC chick embryo cell
CEC Chlorethylclonidine
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
  • JrId: 2838
    JournalTitle: Cell biophysics.
    MedAbbr: Cell Biophys
    ISSN: 0163-4992
    ESSN:
    IsoAbbr: Cell Biophys.
    NlmId: 8002185
  • JrId: 2839
    JournalTitle: Cell and tissue research.
    MedAbbr: Cell Tissue Res
    ISSN: 0302-766X
    ESSN:
    IsoAbbr: Cell Tissue Res.
    NlmId: 417625
  • JrId: 2840
    JournalTitle: Cell calcium.
    MedAbbr: Cell Calcium
    ISSN: 0143-4160
    ESSN:
    IsoAbbr: Cell Calcium
    NlmId: 8006226
  • JrId: 2841
    JournalTitle: Cell motility.
    MedAbbr: Cell Motil
    ISSN: 0271-6585
    ESSN:
    IsoAbbr: Cell Motil.
    NlmId: 8207421
  • JrId: 2843
    JournalTitle: The Central African journal of medicine.
    MedAbbr: Cent Afr J Med
    ISSN: 0008-9176
    ESSN:
    IsoAbbr:
    NlmId: 372566
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • C50.1
    Central portion of breast
    À¯¹æÀÇ Áß¾ÓºÎ
  • H34.1
    Central retinal artery occlusion
    Á᫐ ¸Á¸· µ¿¸Æ Æó¼â
  • Y51.8
    Centrally acting and adrenergic-neuron-blocking agents, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁßÃß¼º ÀÛ¿ë ¹× ¾Æµå·¹³ÊÁ÷ ´º·Ð Â÷´ÜÁ¦
  • T44.8
    Centrally acting and adrenergic-neuron-blocking agents, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁßÃßÀۿ뼺 ¾Æµå·¹³¯¸°¼º ½Å°æ ºÀ¼â¾à¹°
  • J43.2
    Centrilobular emphysema
    Á߽ɼҿ±¼º Æó±âÁ¾
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 6
¿µ¹® cervix cancer ÇÑ±Û Àڱøñ¾Ï, ÀڱðæºÎ¾Ï
¼³¸í   
  ÀÚ±ÃÀÇ ¸ñÀº ÀÚ±ÃÀÌ Áú°ú ¿¬°áµÈ ºÎÀ§·Î ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ºÎÀ§ÀÌ´Ù. À̰÷ÀÇ »óÇǼ¼Æ÷¿¡¼­ ¹ß»ýÇϴ ¾ÏÀ» Àڱøñ¾ÏÀ̶ó°í ÇÑ´Ù.
  
  Àڱøñ¾ÏÀÇ ¹ß»ýÀ» »ìÆìº¸¸é ÀڱøñÀÇ »óÇǼ¼Æ÷°¡ ¿©·¯ °¡Áö Àڱؿ¡ ÀÇÇØ¼­ Á¤»ó¼¼Æ÷¿Í Â÷À̳ª´Â ¾Ï¼ºº¯È­¸¦ ÇÑ ¼¼Æ÷°¡ »ý±â°Ô µÈ´Ù. ÀÌ ¾Ï¼ºº¯È­¸¦ ÇÑ ¼¼Æ÷´Â Ã³À½¿¡´Â ÀڱøñÀÇ »óÇǼ¼Æ÷ÃþÀÇ ÀϺθ¦ ÀÌ·ç°í ÀÖ°Ô µÈ´Ù. ±×·¯´Ù°¡ Á¡Á¡ ´õ ÁøÇàÀÌ µÇ¸é ¾Ï¼º¼¼Æ÷°¡ Àڱøñ »óÇǼ¼Æ÷ÀÇ ¸ðµç ÃþÀ» ²Ëä¿ì°Ô µÈ´Ù. ±×¸®°í °è¼Ó ÁøÇàÇϸ頻óÇǼ¼Æ÷ÀÇ ¸Ç ¹Ø¿¡ Àִ ¹Ù´Ú¸·À» ¶Õ°í ¹öÆÀÁ¶Á÷À¸·Î Ä§À±ÇØ µé¾î°¡°Ô µÈ´Ù. ¾Ï¼ºº¯È­¸¦ ÇÑ ¼¼Æ÷°¡ ÀÚ±ÃÀÇ »óÇÇÃþÀÇ ÀϺθ¦ Ã¤¿ì´Â °ÍÀ» ÀڱøñÇü¼ºÀÌ»ó(cervical dysplasia)¶ó°í ÇÏ°í ¾Ï¼ºº¯È­¸¦ ÇÑ ¼¼Æ÷°¡ ÀÚ±ÃÀÇ »óÇÇÃþÀ» ¸ðµÎ Ã¤¿ö¹ö·Á Á¤»óÀûÀΠ¼¼Æ÷°¡ ¾ø´Â °æ¿ì¸¦ »óÇdz»¾ÏÁ¾(carcinoma in situ)¶ó°í ÇÑ´Ù. ±×¸®°í ¹Ù´Ú¸·À» ¶Õ°í ¹ØÀÇ ¹öÆÀÁ¶Á÷À¸·Î Ä§¹üÇØ ³ª°¡´Â °æ¿ì¸¦ Ä§À±¾Ï(invasive cancer)¶ó°í ÇÑ´Ù.
  
  Àڱøñ¾ÏÀº ¿©·¯ ¸íÀÇ »ó´ë¿Í ¼º°ü°è¸¦ °¡Áö´Â ¿©ÀÚ, ±×¸®°í Ã¹ ¼º°æÇèÀÇ ³ªÀ̰¡ ¾î¸° ¿©ÀÚ¿¡°Ô¼­ ÈçÇÏ°í ¶Ç »çȸÀû, °æÁ¦Àû ¼öÁØÀÌ ³·Àº »ç¶÷¿¡°Ô¼­ Àß °É¸®´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ÀÌ·± °ÍÀ¸·Î ¹Ì·ç¾î Àڱøñ¼¼Æ÷ÀÇ ¾Ï¼ºº¯È­¿¡´Â ¼ºº´°ú °°Àº °¨¿°ÀÌ Áß¿äÇÒ °ÍÀ¸·Î »ý°¢µÇ°í, ¶Ç ¸î°¡Áö ¹ÙÀÌ·¯½ºÀÇ °¨¿°ÀÌ Àڱøñ¾ÏÀÇ ¿øÀÎÀ̶ó´Â °ÍÀÌ ¹àÇôÁ® ÀÖ´Ù.
  
  Àڱøñ¾ÏÀÇ Áø´Ü¹æ¹ýÀ¸·Î´Â Áú¼¼Æ÷°Ë»ç, ÄÝÆ÷½ºÄÚÇÇ, »ý°Ë(biopsy) µîÀÌ ÀÖ´Ù. ¼¼Æ÷°Ë»ç¶õ Á¶±âÁø´Ü ¸ñÀûÀ¸·Î °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â ¹æ¹ýÀ¸·Î ¼ØºÀÀ¸·Î ÀڱøñÀ»¸¦ ¹®Áú·¯¼­ Àڱøñ»óÇǼ¼Æ÷¸¦ ¾ò°í À̰ÍÀ» Çö¹Ì°æÀ¸·Î °üÂûÇÏ¿© »óÇǼ¼Æ÷ÀÇ º¯È­¸¦ º¸´Â °ÍÀÌ´Ù. ÄÝÆ÷½ºÄÚÇǶõ ÀÚ±ÃÀÇ ¸ñÀ» 4~10¹è Á¤µµ È®´ëÇØ¼­ º¸´Â ÀÏÁ¾ÀÇ È®´ë°æ°Ë»çÀ¸·Î Àڱøñ¾ÏÀ¸·Î ÀÎÇÑ ÀڱøñÀÇ º´Àûº¯È­¸¦ °üÂûÇÏ¿© Áø´ÜÇϴ °ÍÀÌ´Ù. »ý°Ë¶õ Áø´ÜÀ» À§Çؼ­ Á÷Á¢ ÀڱøñÀÇ Á¶Á÷À» ¶¼¾î Ã¤ÃëÇÏ¿© Çö¹Ì°æÀ¸·Î °üÂûÇÏ¿© Áø´ÜÇϴ °ÍÀ¸·Î °¡Àå Á¤È®ÇÑ Áø´Ü¹ýÀÌ´Ù.
  
  Ä¡·á·Î´Â º´ÀÇ ÁøÇàÁ¤µµ¿¡ µû¶ó ´Ù¸£°ÚÁö¸¸ ¾ÏÀÇ ÁøÇàÀÌ °ÅÀÇ ¾ø¾î Çü¼ºÀÌ»óÀ̳ª Á¦ÀÚ¸®¾ÏÁ¾ ¶Ç´Â ¾ÆÁÖ Á¶±Ý Ä§À±ÇÏ¿´À» °æ¿ì¿¡´Â ¼ö¼úÀû¿ä¹ýÀ¸·Î ÀÚ±ÃÀ» ÀûÃâÇϴ °ÍÀÌ Ä¡·áÀÇ ¿øÄ¢ÀÌ°í ¸¹Àº ÁøÇàÀ» º¸¿© ´Ù¸¥ Á¶Á÷À¸·Î ¾ÏÀǠħÀ±ÀÌ ÀÖÀ» °æ¿ì¿¡´Â ¹æ»ç¼± Ä¡·á¸¦ ¿øÄ¢À¸·Î ÇÑ´Ù.
¿µ¹® cervix, neck ÇÑ±Û ¸ñ, °æºÎ
¼³¸í   
  ¸ñ, °æºÎ¸¦ ÁöĪÇϴ ¸». Æ¯È÷ ÀÚ±ÃÀÇ ¸ñÀ» ÁöĪÇϴµ¥ ¾²ÀδÙ.
  
  ¸ñ, °æºÎ
¿µ¹® cesarian section ÇÑ±Û Á¦¿ÕÀý°³
¼³¸í   
  Á¤»óÀûÀ¸·Î ÁúÀ» ÅëÇÑ ºÐ¸¸ÀÌ ¾Æ´Ï¶ó, ¼ö¼ú·Î ¹è¿Í ÀÚ±ÃÀ» Àý°³ÇÏ¿© ±×°÷À» ÅëÇØ¼­ ¾ÆÀ̸¦ ºÐ¸¸Çϴ °ÍÀ» Á¦¿ÕÀý°³¶ó ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cellula
    1. ¼¼Æ÷ 2. ¹úÁý
  • cellular
    ¼¼Æ÷-
  • cellular adhesiveness
    ¼¼Æ÷ºÎÂø¼º
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • cellular antibody
    ¼¼Æ÷Ç×ü
  • cellular cast
    ¼¼Æ÷¿øÁÖ
  • cellular cementum
    ¼¼Æ÷½Ã¸àÆ®Áú
  • cellular immunity
    ¼¼Æ÷¸é¿ª
  • cellular infiltration
    ¼¼Æ÷ħÀ±
  • cellular invagination
    ¼¼Æ÷ÇÔÀÔ
  • cellular ischemia
    ¼¼Æ÷ÇãÇ÷
  • cellular migration
    ¼¼Æ÷À̵¿
  • cellular nevus
    ¼¼Æ÷Ãæ½Ç¸ð¹Ý
  • cellular oncogene
    ¼¼Æ÷Á¾¾çÀ¯ÀüÀÚ
  • cellular protooncogene
    ¼¼Æ÷DzÁ¾¾çÀ¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cell-bound antibody
    (¢¡cell-fixed antibody) ¼¼Æ÷°áÇÕÇ×ü
  • cell-fixed antibody
    ¼¼Æ÷°áÇÕÇ×ü
  • cell-mediated cytolysis
    ¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
  • cell-mediated cytotoxicity
    ¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • cell-mediated hypersensitivity
    ¼¼Æ÷¸Å°³°ú¹Î
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
  • cell-mediated lympholysis test
    ¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
  • cell-mediated reaction
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • cell-mediated response
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • cella
    ¼Ò¹æ, ¼Ò½Ç
  • cellobiose
    ¼¿·Îºñ¿À½º
  • celloidin section
    ¼¿·ÎÀ̵òÀýÆí
  • cellophane maculopathy
    ¼¿·ÎÆÇȲ¹Ýº´Áõ
  • cellophane thick smear
    ¼¿·ÎÆÇÈÄÃþ¹Ù¸¥Ç¥º», ¼¿·ÎÆÇµÎÅÓ°Ô¹Ù¸¥Ç¥º»
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • celiodynia =celialgia
    »êÅë, º¹Åë.
  • celioelytrotomy
    º¹½ÄÁúÀý°³(¼ú)(ÜÙãÒòóôîËÒâú).
  • celioenterotomy
    º¹½ÄÀå°üÀý°³(¼ú)(¡­Àå°üü°³¼ú).
  • celiogastrotomy
    º¹½ÄÀ§Àý°³(¼ú)(º¹½ÄÀ§Ã¼°³¼ú).
  • celiohysterectomy
    º¹½ÄÀÚ±ÃÀûÃâ(¼ú)(¡­î×õóâú).
  • celiomyomectomy
    º¹½Ä±ÙÁ¾ÀýÁ¦(¼ú)(º¹½Ä±ÙÁ¾Ã¼Á¦¼ú).
  • celiomyositis
    º¹(º®)±Ù¿°(º¹º®±Ù¿°).
  • celiomyositis
    º¹(º®)±Ù¿°(ÜÙÛúÐÉæú).
  • celiopathy
    º¹ºÎº´Áõ(º¹ºÎº´Áõ).
  • celiopathy
    º¹ºÎº´Áõ(ÜÙݻܻñø).
  • celiopyosis
    º¹°­È­³óÁõ(º¹°­È­³óÁõ).
  • celiorraphy
    º¹º®ºÀÇÕ(º¹º®ºÀÇÕ).
  • celiosalpingectomy
    º¹°­³­°üÀýÁ¦¼ú.
  • celiosalpingooophorectomy
    º¹°­³­°ü³­¼ÒÀýÁ¦¼ú.
  • celiosalpingotomy
    º¹½Ä³­°üÀý°³(¼ú).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Cephalic mesoderm
    ¸Ó¸®Á߹迱
    [¿¾ ¿ë¾î] µÎºÎÁ߹迱
  • Cephalic vein
    ³ëÂÊÇǺÎÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿äÃøÇÇÁ¤¸Æ
  • Ceratohyoid cartilage
    ¸ñ»Ô»ÀÀÛÀº»Ô¿¬°ñ
    [¿¾ ¿ë¾î] ¼³°ñ¼Ò°¢¿¬°ñ
  • Ceratopharyngeal part
    Å«»ÔÀεκκÐ
    [¿¾ ¿ë¾î] ´ë°¢ÀεκÎ
  • Cerebellar cortex
    ¼Ò³ú°ÑÁú
    [¿¾ ¿ë¾î] ¼Ò³úÇÇÁú
  • Cerebellar fissures
    ¼Ò³ú°í¶û
    [¿¾ ¿ë¾î] ¼Ò³ú±¸
  • Cerebellar folia
    ¼Ò³úÀ̶û
    [¿¾ ¿ë¾î] ¼Ò³úȸ
  • Cerebellar fossa
    ¼Ò³ú¿ì¹¬
    [¿¾ ¿ë¾î] ¼Ò³ú¿Í
  • Cerebellar hemisphere
    ¼Ò³ú¹Ý±¸
    [¿¾ ¿ë¾î] ¼Ò³ú¹Ý±¸
  • Cerebellar nuclei
    ¼Ò³úÇÙ
    [¿¾ ¿ë¾î] ¼Ò³úÇÙ
  • Cerebellar peduncles
    ¼Ò³ú´Ù¸®
    [¿¾ ¿ë¾î] ¼Ò³ú°¢
  • Cerebellar tonsillar branch
    ¼Ò³úÆíµµ°¡Áö
    [¿¾ ¿ë¾î] ¼Ò³úÆíµµÁö
  • Cerebellar veins
    ¼Ò³úÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò³úÁ¤¸Æ
  • Cerebellar Vermis
    ¼Ò³ú¹ú·¹
    [¿¾ ¿ë¾î] ¼Ò³úÃæºÎ
  • Cerebellum
    ¼Ò³ú
    [¿¾ ¿ë¾î] ¼Ò³ú
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • cerebral c.
    ´ë³ú°ÑÁú, ´ë³úÇÇÁú
    ÓÞÒàù«òõ
  • cerebral cortical l.
    ³ú°ÑÁú±â´ÉÀ§Ä¡È­
    ³ú°ÑÁúѦÒöêÈöÇûù
  • cerebral f.
    ³úÆ´»õ, ³ú±¸, ³ú¿­
    Òàϵ,Òàæñ
  • cerebral h.
    ´ë³ú¹Ý±¸
    ÓÞÒàÚâϹ
  • cerebral h.
    ´ë³úÃâÇ÷
    ÓÞÒàõóúì
  • cerebral h.
    ´ë³ú Å»Ãâ
    ÓÞÒà ÷­õó
  • cerebral i.
    ³ú°æ»ö(Áõ)
    ÒàÌÛßá
  • cerebral metabolic r. (CMR)
    ³ú´ë»çÀ²
    ÒàÓÛÞóëÒ
  • cerebral metabolic rate of oxygen c.(CMRO2)
    ´ë³ú»ê¼Ò¼Òºñ´ë»çÀ²
    ÓÞÒàß«áÈá¼Þ¨ÓÛÞóëÒ
  • cerebral p.
    ³ú¼º¸¶ºñ
    ÒààõئÝö
  • cerebral p.
    ³úÆóÈíÃæÁõ
    ÒàøËýåõùñø
  • cerebral p.
    ´ë³ú´Ù¸®
  • cerebral s.
    ´ë³ú°í¶û, ´ë³ú±¸
    ÓÞÒàϵ
  • cerebral salt-wasting s.
    ´ë³ú¿°·ùÀ¯Ãâ ÁõÈıº
    (ÓÞ)Òà ç¤×¾êüõó ñøý¦ÏØ
  • cerebral spastic d.
    ³ú¼º°æÁ÷¾çÃø¸¶ºñ
    ÒààõÌãòÁå»ö°Ø¦Ýö
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cervicovesical
    ÀÚ±Ã°æ¹æ±¤ÀÇ
  • cervix
    ¸ñ, °æ
  • cervix uteri
    Àڱøñ, ÀڱðæºÎ
  • Cesarean section
    Á¦¿ÕÀý°³¼ú, Á¦Àý
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell sorting
    ¼¼Æ÷ ºÐ·ù
  • cell substitution
    ¼¼Æ÷ ġȯ, Ç÷±¸ Àç»ý
  • cell surface marker
    ¼¼Æ÷ Ç¥¸é Ç¥ÁöÀÚ
  • cell survival curve
    ¼¼Æ÷ »ýÁ¸ °î¼±
  • cell transfer
    ¼¼Æ÷ ÀÌÀÔ
    Á¼Àº Àǹ̿¡¼­´Â °¢Á¾ ¼¼Æ÷¸¦ ¹æ»ç¼± Á¶»ç µîÀÇ Ã³¸®¸¦ °¡ÇÑ µ¿¹°¿¡ ÁÖÀÔÇϰí ÁÖÀÔµÈ ¼¼Æ÷ÀÇ ¼º»óÀ» Á¶»çÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ ¼¼Æ÷ ÁÖÀÔÀÇ ¹æ¹ýÀ» °¡¸®Å°¸ç in vitro¿¡¼­ ¼¼Æ÷ ±â´ÉÀ» Á¶»çÇϱⰡ °ï¶õÇÑ °æ¿ì, in vivo¿¡¼­ÀÇ ¹ÝÀÀ¼ºÀ» Á¶»çÇÏ°í ½ÍÀº °æ¿ì, ¶Ç chimera mouse¸¦ Á¦ÀÛÇÒ ¶§¿¡ »ç¿ëµÈ´Ù. ³ÐÀº Àǹ̿¡¼­´Â ¼¼Æ÷°¡ ÇÑÆí¿¡¼­ ´Ù¸¥ ÆíÀ¸·Î À̵¿ÇÏ´Â °ÍÀ» °¡¸®Å²´Ù.
  • cell typing
    Ç÷±¸Çü °Ë»ç
  • cell wall
    ¼¼Æ÷ º®
    µ¿ÀǾî=cell membrane.
  • cell wall inhibitor
    ¼¼Æ÷ º® ÇÕ¼º ¾ïÁ¦Á¦
  • cell wall teichoic acid
    ¼¼Æ÷ º® ŸÀÌÄÚ»ê
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º
  • cell-mediated cytotoxicity
    ¼¼Æ÷ ¸Å°³¼º ¼¼Æ÷ µ¶¼º
    Ç×ü ȤÀº lym
  • cell-mediated hypersensitivity
    ¼¼Æ÷ ¸Å°³¼º °ú¹ÎÁõ
    TuberculinÇü Çdz» ¹ÝÀÀÀ» ´ëÇ¥·Î ÇÑ´Ù. ¼¼Æ÷¼º ¸é¿ª ¹ÝÀÀÀÇ ÇÑ ÇüÅÂ. Ç׿ø¿¡ ÀÇÇÏ¿© °¨ÀÛµÈ µ¿¹°ÀÇ Çdz»¿¡ ÀçÂ÷ Ç׿øÀ» ÁÖ»çÇÔÀ¸·Î½á ¼ö ½Ã°£À¸·ÎºÎÅÍ 36½Ã°£ ÈÄ¿¡ ¹ßÀû, °æ°áÀ» ¼ö¹Ý½ÃŰ´Â Á¾Ã¢ÀÌ ÁÖ»ç ºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¹ÝÀÀÀÌ´Ù.
  • cell-mediated immunity
    ¼¼Æ÷ ¸Å°³ ¸é¿ª, ¼¼Æ÷ ¸Å°³¼º ¸é¿ª
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¼º ¸é¿ª °áÇÌ ÁõÈıº
  • cella
    ¼Ò¹æ, ¼Ò½Ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
celiotomy incision An incision through the abdominal wall.
(05 Mar 2000)
celiprolol <chemical> A cardioselective beta-1-adrenergic antagonist that may act as a partial agonist at some adrenergic sites.
Pharmacological action: adrenergic beta-antagonists, anti-arrhythmia agents, antihypertensive agents, sympatholytics, vasodilator agents.
Chemical name: Urea, N'-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethyl-
(12 Dec 1998)
celitis Any inflammation of the abdomen.
Origin: G. Koilia, belly, + -itis, inflammation
(05 Mar 2000)
cell <cell biology> An autonomous self replicating unit (in principle) that may constitute an organism (in the case of unicellular organisms) or be a sub unit of multicellular organisms in which individual cells may be more or less specialised differentiated) for particular functions.
The individual units from which tissues of the body are formed. All living organisms are composed of one or more cells.
(26 Mar 1998)
cell adhesion See: adhesins, cadherins, cell adhesion molecules (CAMs), contact sites A, DLVO theory, integrins, sorting out, uvomorulin and various specialised junctions (adherens junctions, desmosomes, focal adhesions, gap junction and zonula occludens).
(18 Nov 1997)
cell adhesion kinase <enzyme> From hela cells; involved in cell-cell interactions; genbank l20817
Registry number: EC 2.7.1.-
Synonym: cak protein
(26 Jun 1999)
cell adhesion molecule <molecular biology> Although this could mean any molecule involved in cellular adhesive phenomena, it has acquired a more restricted sense, namely a molecule on the surface of animal tissue cells, antibodies (or Fab fragments) against that specifically inhibit some form of intercellular adhesion.
Examples are Liver Cell Adhesion Molecule and Neural Cell Adhesion Molecule, both named from tissues in which first detected, although their occurrence is not in fact restricted to these.
Acronym: CAM
(26 Nov 1998)
cell adhesion molecules Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.
(12 Dec 1998)
cell adhesion molecules, neuron-glia Cell adhesion molecules that mediate neuron-neuron adhesion and neuron-astrocyte adhesion. They are expressed on neurons and schwann cells, but not astrocytes and are involved in neuronal migration, neurite fasciculation, and outgrowth. Ng-cam is immunologically and structurally distinct from ncam (neural cell adhesion molecules).
(12 Dec 1998)
cell adhesion molecules, neuronal Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with ncam (neural cell adhesion molecule), now known to be expressed in a variety of tissues and cell types in addition to nervous tissue.
(12 Dec 1998)
cell aggregation The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.
(12 Dec 1998)
cell aging The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of apoptosis.
(12 Dec 1998)
cell behaviour <cell biology> General term for activities of whole cells such as movement, adhesion and proliferation, by analogy with animal behaviour.
(18 Nov 1997)
cell biology <study> The study of the internal workings of cells at the microscopic and molecular level - it is closely linked to molecular biology.
(16 Dec 1997)
cell body Used in reference to neurons, the main part of the cell around the nucleus excluding long processes such as axons and dendrites.
(18 Nov 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 6
  • Cefoxitin - »õâ A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
    Synonyms : Cefoxitin Sodium, MK-306, MSD Brand of Cefoxitin Sodium, Mefoxin, Mefoxitin, Merck Brand of Cefoxitin Sodium, Merck Frosst Brand of Cefoxitin Sodium, Merck Sharp & Dohme Brand of Cefoxitin Sodium, Mefoxin, Pharmacia Brand of Cefoxitin Sodium, MK 306, MK306
  • Cefsulodin - »õâ A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
    Synonyms : Abbott 46811, CGP-7174-E, Cefsulodin Monosodium Salt, Cefsulodin Sodium, Monaspor, Pyocefal, SCE-129, Takeda Brand of Cefsulodin Sodium, CGP 7174 E, CGP7174E, Monosodium Salt, Cefsulodin, SCE 129, SCE129, Salt, Cefsulodin Monosodium, Sodium, Cefsulodin
  • Ceftazidime - »õâ Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
    Synonyms : Fortaz, Fortum, GR-20263, LY-139381, Tazidime, GR 20263, GR20263, LY 139381, LY139381
  • Ceftizoxime - »õâ A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
    Synonyms : Cefizox, Ceftizoxime Monosodium Salt, FK-749, FK749, FR-13749, Fujiwasa Brand of Cetizoxime Sodium, GlaxoSmithKline Brand of Cetizoxime Sodium, SK&F 88373-2, SKF-88373, Yamanouchi Brand of Ceftizoxime Sodium, FK 749, FR 13749, FR13749, Monosodium Salt, Ceftizoxime
  • Ceftriaxone - »õâ A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
    Synonyms : Benaxona, Boehringer Mannheim Brand of Ceftriaxone Sodium, Cefatriaxone, Cefaxona, Ceftrex, Ceftriaxon, Ceftriaxon Curamed, Ceftriaxon Hexal, Ceftriaxona Andreu, Ceftriaxona LDP Torlan, Ceftriaxone Irex, Ceftriaxone Sodium, Ceftriaxone Sodium, Anhydrous, Lendacin
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 6 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¼¼ÆÄŬ¸°°ÇÁ¶½Ã·´ - »õâ
°æµ¿Á¦¾à
A17603191 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
Çѱ¹À¯³ªÀÌÆ¼µå¼¼ÆÄŬ·¯°ÇÁ¶½Ã·´ - »õâ
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à
A12994041 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
´ë¿õ¼¼ÆÄŬ·¯°ÇÁ¶½Ã·´125mg/5ml - »õâ
´ë¿õÁ¦¾à
A82350021 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
½ÃŬ·¯°ÇÁ¶½Ã·´125mg/5ml - »õâ
Çѱ¹¸±¸®
W31490011 Cefaclor
Àü¹®ÀǾàǰ | »èÁ¦
¼¼Å¬·º½º°ÇÁ¶½Ã·´ - »õâ
µ¿¼ºÁ¦¾à
A06702911 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ·º½º°ÇÁ¶½Ã·´ - »õâ
ÄÚ¿À·ÕÁ¦¾à
A04703971 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
µ¿½Å¼¼ÆÄŬ·¯°ÇÁ¶½Ã·´ - »õâ
µ¿½ÅÁ¦¾à
A15106481 Cefaclor
Àü¹®ÀǾàǰ | »èÁ¦
Å©·Î¼¼ÇÁ°ÇÁ¶½Ã·´ - »õâ
Çѹ̾àǰ
A21402021 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
À¯ÇѼ¼ÆÄŬ·¯°ÇÁ¶½Ã·´ - »õâ
À¯ÇѾçÇà
A04505311 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
ÆÄŬ°ÇÁ¶½Ã·´ - »õâ
»ïõ´çÁ¦¾à
A08402691 Cefaclor
Àü¹®ÀǾàǰ | ±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
Cefobid cefoperazone: a parenteral cephalosporin (trade name Cefobid) used for severe infections
Ãâó: wordnet.princeton.edu/perl/webwn
ceftazidime a parenteral cephalosporin (trade names Fortaz and Tazicef) used to treat moderate infections
Ãâó: wordnet.princeton.edu/perl/webwn
Ceftin cefuroxime: a cephalosporin that can be given parenterally (trade name Zinacef) or orally by tablets (trade name Ceftin); indicated for infections of the lungs or throat or ears or urinary tract or meninges
Ãâó: wordnet.princeton.edu/perl/webwn
cefuroxime a cephalosporin that can be given parenterally (trade name Zinacef) or orally by tablets (trade name Ceftin); indicated for infections of the lungs or throat or ears or urinary tract or meninges
Ãâó: wordnet.princeton.edu/perl/webwn
Cestoda tapeworms
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • celestial globe
    õ±¸ÀÇ
  • celestial guidance
    (·Î°ÙÀÇ) õÃàÀ¯µµ
  • celestial hierarchy
    õ±º ±¸´ë
  • celestial latitude
    ȲÀ§
  • celestial longitude
    Ȳ°æ
  • celestial mechanics
    õü ¿ªÇÐ
  • celestial navigation
    õ¹® Ç×¹ý 9
  • celestial pole
    õ±¸ÀÇ ±Ø
  • celestial sphere
    õ±¸
  • Celia
    (¿©ÀÚÀ̸§)
  • celiac
    ¹èÀÇ
  • celiac
    º¹°­ÀÇ
  • celiac disease
    ¼Ò¾ÆÁö¹æº¯Áõ
  • celibacy
    µ¶½Å
  • celibacy
    (ƯÈ÷ ¼öµµ»çÀÇ Á¾±³ÀûÀÎ)µ¶½Å(»ýȰ);µ¶½ÅÁÖÀÇ;±Ý¿å
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 6
CE the act of ceding back
CE tropical American trees
CE Philippine timber tree having hard red fragrant wood
CE tropical American tree yielding fragrant wood used especially for boxes
CE true cedars
CE tall Algerian evergreen of Atlas mountains with blue-green leaves
CE tall East Indian cedar having spreading branches with nodding tips
CE cedar of Lebanon and northwestern Syria that attains great age and height
CE a cephalosporin antibiotic (trade name Ultracef)
CE a parenteral cephalosporin (trade name Cefobid) used for severe infections
CE a parenteral cephalosporin (trade name Cefobid) used for severe infections
CE a parenteral cephalosporin (trade name Claforan) used for severe infections of the lungs or throat or ears or urinary tract
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 6
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á